PubRank

Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe Preeclampsia (ADENA)

Clinical Trial ID NCT02286284

PubWeight™ 0.80‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02286284

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003 13.72
2 Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol 2003 8.95
3 Pre-eclampsia. Lancet 2010 7.46
4 Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003 6.44
5 A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008 3.39
6 Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003 3.36
7 Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 2011 3.33
8 First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004 2.11
9 Low-density lipoprotein apheresis therapy during pregnancy. Am J Cardiol 2000 1.52
10 Home blood-pressure monitoring in patients receiving sunitinib. N Engl J Med 2008 1.36
11 Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol 2006 1.28
12 Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation. Am J Obstet Gynecol 2004 1.15
13 Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction. Am J Obstet Gynecol 2011 0.82
14 HELP LDL-apheresis in two cases of familial hypercholesterolemic pregnant women. Transfus Apher Sci 2011 0.82
15 Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery. Circulation 2015 0.80
16 [Criteria of pregnancy termination in women with preeclampsia]. Ann Fr Anesth Reanim 2010 0.77
17 Why preeclampsia still exists? Med Hypotheses 2013 0.75
18 Development of a nomogram to predict occurrence of preeclampsia. Eur J Obstet Gynecol Reprod Biol 2007 0.75
Next 100